Ubs Oconnor LLC Bausch & Lomb Corp Transaction History
Ubs Oconnor LLC
- $1.51 Billion
- Q4 2024
A detailed history of Ubs Oconnor LLC transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Ubs Oconnor LLC holds 52,460 shares of BLCO stock, worth $879,754. This represents 0.06% of its overall portfolio holdings.
Number of Shares
52,460Holding current value
$879,754% of portfolio
0.06%Shares
2 transactions
Others Institutions Holding BLCO
# of Institutions
124Shares Held
36.5MCall Options Held
91.6KPut Options Held
293K-
Icahn Carl C Sunny Isles Beach, FL3.5MShares$58.7 Million0.86% of portfolio
-
Maple Rock Capital Partners Inc. Toronto, A63.17MShares$53.2 Million1.8% of portfolio
-
Alberta Investment Management Corp Edmonton, A03.01MShares$50.4 Million0.41% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.88MShares$31.6 Million0.03% of portfolio
-
Goldentree Asset Management LP New York, NY1.73MShares$29 Million2.37% of portfolio
About Bausch & Lomb Corp
- Ticker BLCO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 350,000,000
- Market Cap $5.87B
- Description
- Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...